A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia

A Retrospective Study in Patients With Mild to Moderate COVID-19

NCT05374772 ·Status: UNKNOWN

Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia

NCT00270517 ·Status: UNKNOWN ·Phase: PHASE2

Chinese Hospital Acquired Pneumonia Collaboration Network: Epidemiology, Diagnosis and Treatment

NCT06028217 ·Status: NOT_YET_RECRUITING

Prophylaxis and Treatment of COVID-19

NCT04844541 ·Status: COMPLETED

Clinical Trials to Reduce the Risk of Antimicrobial Resistance

NCT01570192 ·Status: TERMINATED ·Phase: PHASE2

Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa

NCT03409679 ·Status: TERMINATED ·Phase: PHASE3

Bacteriophage Cocktail Therapy for Multidrug-Resistant Gram-Negative Ventilator-Associated Pneumonia

NCT07202234 ·Status: NOT_YET_RECRUITING ·Phase: NA

Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults

NCT01940731 ·Status: UNKNOWN ·Phase: PHASE2

High-dose Inhalations of Nitric Oxide in the Treatment of Pneumonia

NCT06170372 ·Status: RECRUITING ·Phase: NA

FilmArray Pneumonia Panel for Antimicrobial Treatment of HAP/VAP in Intensive Care Units

NCT05214716 ·Status: TERMINATED ·Phase: NA

Early Identification and Severity Prediction of Acute Respiratory Infectious Disease

NCT04955756 ·Status: UNKNOWN ·Phase: NA

A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia

NCT01937832 ·Status: UNKNOWN ·Phase: PHASE3

Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU

NCT00307099 ·Status: TERMINATED ·Phase: PHASE3

Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumonia.

NCT07086391 ·Status: RECRUITING

Clinical Features, Outcome and Prognosis of Human Metapneumovirus (hMPV) Lower Respiratory Tract Infections in Adult Inpatients

NCT03460171 ·Status: UNKNOWN

Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.

NCT05123755 ·Status: RECRUITING ·Phase: PHASE2

Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients

NCT04324047 ·Status: UNKNOWN

Model-informed Individualized Treatment of Anti-Infective Drugs in Patients With Spinal Infections

NCT06711575 ·Status: RECRUITING

A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia

NCT01886053 ·Status: COMPLETED ·Phase: PHASE2

Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 Infection

NCT04371471 ·Status: COMPLETED

Improving Antibiotic Use in Acute Care Treatment

NCT00144040 ·Status: COMPLETED ·Phase: NA

Drug Resistance Factors In Healthcare-associated Pneumonia

NCT02736097 ·Status: COMPLETED

Respiratory Virome Diversity and Baseline Immunity in Healthy Individuals in Shanghai

NCT06641856 ·Status: RECRUITING

Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia

NCT04709172 ·Status: COMPLETED ·Phase: PHASE4

Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections

NCT01917461 ·Status: COMPLETED